Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial
Restricted accessResearch articleFirst published online June, 2022
Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial
Alterations in the serotonergic control of brain pathways responsible for facial emotion processing in people with autism spectrum disorder (ASD) may be a target for intervention. However, the molecular underpinnings of autistic-neurotypical serotonergic differences are challenging to access in vivo. Receptor-Enriched Analysis of functional Connectivity by Targets (REACT) has helped define molecular-enriched functional magnetic resonance imaging (fMRI) brain networks based on a priori information about the spatial distribution of neurochemical systems from available PET templates.
Methods:
We used REACT to estimate the dominant fMRI signal related to the serotonin (5-HT) transporter (SERT) distribution during processing of aversive facial emotion in adults with and without ASD. We first predicted a group difference in baseline (placebo) functioning of this system. We next used a single 20 mg oral dose of citalopram, a serotonin reuptake inhibitor, to test the hypothesis that network activity in people with and without ASD would respond differently to inhibition of SERT. To confirm the specificity of our findings, we also repeated the analysis with 5-HT1A, 5-HT1B, 5-HT2A and 5-HT4 receptor maps.
Results:
Using REACT with the SERT map, we found a baseline group difference in the SERT-enriched response to faces in the ventromedial prefrontal cortex. A single oral dose of citalopram ‘shifted’ the response in the ASD group towards the neurotypical baseline but did not alter response in the control group. Similar differences in SERT-enriched response were observed after controlling for other 5-HT maps.
Conclusions:
Our findings suggest that the SERT-enriched functional network is dynamically different in ASD during processing of socially relevant stimuli. Whether this acute neurobiological response to citalopram in ASD translates to a clinical target will be an important next step.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
2.
AnderssonMTangenÄFardeL, et al. (2021) Serotonin transporter availability in adults with autism – A positron emission tomography study. Molecular Psychiatry26: 1647–1658.
3.
AshwinCBaron-CohenSWheelwrightS, et al. (2007) Differential activation of the amygdala and the ‘social brain’ during fearful face-processing in Asperger syndrome. Neuropsychologia45(1): 2–14.
4.
BeliveauVGanzMFengL, et al. (2017) A high-resolution in vivo atlas of the human brain’s serotonin system. Journal of Neuroscience37(1): 120–128.
5.
BullmoreETWilliamsSCRRingHA, et al. (2002) The amygdala theory of autism. Neuroscience & Biobehavioral Reviews24(3): 355–364.7
6.
ChamberlainSRMüllerUBlackwellAD, et al. (2006) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science311(5762): 861–863.
7.
CirannaL (2006) Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: Implications in physiological functions and in pathology. Current Neuropharmacology4(2): 101–114.
8.
CremersHRWagerTDYarkoniT (2017) The relation between statistical power and inference in fMRI. PLoS ONE12(11): e0184923.
9.
CritchleyHDDalyEMBullmoreET, et al. (2000) The functional neuroanatomy of social behaviour. Brain: A Journal of Neurology123(Pt 11): 2203–2212.
10.
CroenLAGretherJKYoshidaCK, et al. (2011) Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry68(11): 1104–1112.
11.
DaltonKMNacewiczBMJohnstoneT, et al. (2005) Gaze fixation and the neural circuitry of face processing in autism. Nature Neuroscience8(4): 519–526.
12.
DalyEMDeeleyQEckerC, et al. (2012) Serotonin and the neural processing of facial emotions in adults with autism: An fMRI study using acute tryptophan depletion. Archives of General Psychiatry69(10): 1003–1013.
13.
DalyEMDeeleyQHallahanB, et al. (2010) Effects of acute tryptophan depletion on neural processing of facial expressions of emotion in humans. Psychopharmacology210(4): 499–510.
14.
DalyEMEckerCHallahanB, et al. (2014) Response inhibition and serotonin in autism: A functional MRI study using acute tryptophan depletion. Brain: A Journal of Neurology137(Pt 9): 2600–2610.
15.
DayTCMcNaughtonKANaplesAJ, et al. (2020) Self-reported social impairments predict depressive disorder in adults with autism spectrum disorder. Autism24(2): 297–306.
16.
Del-BenCMDeakinJFMcKieS, et al. (2005) The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: An fMRI study. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology30(9): 1724–1734.
17.
DesikanRSSégonneFFischlB, et al. (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage31(3): 968–980.
18.
DeutschSIRaffaeleCT (2019) Understanding facial expressivity in autism spectrum disorder: An inside out review of the biological basis and clinical implications. Progress in Neuro-Psychopharmacology and Biological Psychiatry88: 401–417.
19.
DipasqualeOMartinsDSethiA, et al. (2020) Unravelling the effects of methylphenidate on the dopaminergic and noradrenergic functional circuits. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology45(9): 1482–1489.
20.
DipasqualeOSelvaggiPVeroneseM, et al. (2019) Receptor-enriched analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA. NeuroImage195: 252–260.
21.
EickhoffSBStephanKEMohlbergH, et al. (2005) A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. NeuroImage25: 1325–1335.
22.
GarbarinoVRGilmanTLDawsLC, et al. (2019) Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacological Research140: 85–99.
23.
GirgisRRSlifsteinMXuX, et al. (2011) The 5-HT 2A receptor and serotonin transporter in Asperger’s disorder: A PET Study with [11C]MDL 100907 and [11C]DASB. Psychiatry Research – Neuroimaging194: 230–234.
24.
GobbiniMIHaxbyJV (2007) Neural systems for recognition of familiar faces. Neuropsychologia45(1): 32–41.
25.
HamiltonM (1959) The assessment of anxiety states by rating. The British Journal of Medical Psychology32(1): 50–55.
26.
HamiltonM (1960) A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry23: 56–63.
27.
HaririARTessitoreAMattayVS, et al. (2002) The amygdala response to emotional stimuli: A comparison of faces and scenes. NeuroImage17(1): 317–323.
28.
HarmerCJRogersRDTunbridgeE, et al. (2003) Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology167(4): 411–417.
29.
HowesODRogdakiMFindonJL, et al. (2018) Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. Journal of Psychopharmacology32(1): 3–29.
30.
HranilovicDBujas-PetkovicZVragovicR, et al. (2007) Hyperserotonemia in adults with autistic disorder. Journal of Autism and Developmental Disorders37(10): 1934–1940.
31.
HyttelJ (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). International Clinical Psychopharmacology9(Suppl. 1): 19–26.
32.
JacksonMEMoghaddamB (2018) Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. The Journal of Neuroscience21(2): 676–681.
33.
JenkinsonMBeckmannCFBehrensTEJ, et al. (2012) FSL. NeuroImage62(2): 782–790.
34.
LaiMCLombardoMVBaron-CohenS (2014) Autism. The Lancet383(9920): 896–910.
35.
LombardoMVLaiMCBaron-CohenS (2019) Big data approaches to decomposing heterogeneity across the autism spectrum. Molecular Psychiatry24(10): 1435–1450.
36.
LordCRutterMGoodeS, et al. (1989) Austism diagnostic observation schedule: A standardized observation of communicative and social behavior. Journal of Autism and Developmental Disorders19(2): 185–212.
37.
MackeySPetridesM (2014) Architecture and morphology of the human ventromedial prefrontal cortex. The European Journal of Neuroscience40(5): 2777–2796.
38.
MakkonenIRiikonenRKokkiH, et al. (2008) Serotonin and dopamine transporter binding in children with autism determined by SPECT. Developmental Medicine and Child Neurology50(8): 593–597.
39.
MoessnangCBaumeisterSTillmannJ, et al. (2020) Social brain activation during mentalizing in a large autism cohort: The Longitudinal European Autism Project. Molecular Autism11(1): 17.
40.
MullerCLAnackerAMJVeenstra-VanderWeeleJ (2016) The serotonin system in autism spectrum disorder: From biomarker to animal models. Biological Psychiatry321: 24–41.
41.
MurphySELonghitanoCAyresRE, et al. (2006) Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology187(1): 121–130.
42.
NakamuraKSekineYOuchiY, et al. (2010) Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Archives of General Psychiatry67(1): 59–68.
43.
NickersonLDSmithSMÖngürD, et al. (2017) Using dual regression to investigate network shape and amplitude in functional connectivity analyses. Frontiers in Neuroscience11: 115.
44.
OakleyBFMJonesEJHCrawleyD, et al. (2020) Alexithymia in autism: Cross-sectional and longitudinal associations with social-communication difficulties, anxiety and depression symptoms. Psychological Medicine. Epub ahead of print 8 October. DOI: 10.1017/S0033291720003244.
45.
PinkhamAEHopfingerJBPelphreyKA, et al. (2008) Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophrenia Research99(1–3): 164–175.
46.
PourhamzehMMoravejFGArabiM, et al. (2021) The roles of serotonin in neuropsychiatric disorders. Cellular and Molecular Neurobiology. Epub ahead of print 2 March. DOI: 10.1007/s10571-021-01064-9.
47.
PowerJDBarnesKASnyderAZ, et al. (2012) Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. NeuroImage59(3): 2142–2154.
48.
ReddihoughDSMarraffaCMoutiA, et al. (2019) Effect of fluoxetine on obsessive-compulsive behaviors in children and adolescents with autism spectrum disorders: A randomized clinical trial. Journal of the American Medical Association (JAMA)322(16): 1561–1569.
49.
ReiersenAMToddRD (2008) Co-occurrence of ADHD and autism spectrum disorders: Phenomenology and treatment. Expert Review of Neurotherapeutics8(4): 657–669.
50.
RiadMWatkinsKCDoucetE, et al. (2001) Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). Journal of Neuroscience21: 8378–8386.
51.
SakuraiTReichertJHoffmanEJ, et al. (2008) A large-scale screen for coding variants in SERT/SLC6A4 in autism spectrum disorders. Autism Research: Official Journal of the International Society for Autism Research1(4): 251–257.
SchurzMRaduaJAichhornM, et al. (2014) Fractionating theory of mind: A meta-analysis of functional brain imaging studies. Neuroscience and Biobehavioral Reviews42: 9–34.
54.
SelvarajSMouchlianitisEFaulknerP, et al. (2014) Presynaptic serotoninergic regulation of emotional processing: A multimodal brain imaging study. Biological Psychiatry78: 563–571.
55.
SelvarajSTurkheimerFRossoL, et al. (2012) Measuring endogenous changes in serotonergic neurotransmission in humans: A [11C] CUMI-101 PET Challenge Study. Molecular Psychiatry17(12): 1254–1260.
56.
SelvarajSWalkerCArnoneD, et al. (2018) Effect of citalopram on emotion processing in humans: A combined 5-HT1A [11C]CUMI-101 PET and Functional MRI Study.Neuropsychopharmacology43(3): 655–664.
57.
SmithSMNicholsTE (2009) Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage44: 83–98.
58.
SutcliffeJSDelahantyRJPrasadHC, et al. (2005) Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. American Journal of Human Genetics77(2): 265–279.
59.
Van DonkelaarELBloklandAFerringtonL, et al. (2011) Mechanism of acute tryptophan depletion: Is it only serotonin. Molecular Psychiatry16(7): 695–713.
60.
WichersRFindonJJelsmaA, et al. (2019) Modulation of brain activation during executive functioning in autism with citalopram. Translational Psychiatry9(1): 286.
61.
WickerBFonluptPHubertB, et al. (2008) Abnormal cerebral effective connectivity during explicit emotional processing in adults with autism spectrum disorder. Social Cognitive and Affective Neuroscience3(2): 135–143.
62.
WilliamsKWheelerDMSiloveN, et al. (2011) Cochrane review: Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Evidence-Based Child Health: A Cochrane Review Journal6(4): 1044–1078.
63.
WinklerAMRidgwayGRWebsterMA, et al. (2014) Permutation inference for the general linear model. NeuroImage92: 381–397.
64.
WongNMLFindonJLWichersRH, et al. (2020) Serotonin differentially modulates the temporal dynamics of the limbic response to facial emotions in male adults with and without autism spectrum disorder (ASD): A randomised placebo-controlled single-dose crossover trial. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology45(13): 2248–2256.
65.
WoodJJGadowKD (2010) Exploring the nature and function of anxiety in youth with autism spectrum disorders. Clinical Psychology: Science and Practice17(4): 281–292.
66.
YoungSNTeffKL (1989) Tryptophan availability, 5HT synthesis and 5HT function. Progress in Neuro-Psychopharmacology & Biological Psychiatry13(3–4): 373–379.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
